FDA.reportPublic FDA data

Sunlenca 463.5 MG per 1.5 ML Injection

RxCUI
2625909
RxNorm name
Sunlenca 463.5 MG per 1.5 ML Injection
Display name
Sunlenca 463.5 MG per 1.5 ML Injection
Full name
Sunlenca 463.5 MG per 1.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SunlencaLENACAPAVIR SODIUMGilead Sciences, Inc.e5652804-29c4-40d7-aeb2-0142ed2a7b5b2026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 2625909

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e5652804-29c4-40d7-aeb2-0142ed2a7b5bSunlenca 463.5 MG in 1.5 ML Injection [PSN] · 1.5 ML lenacapavir 309 MG/ML Injection [Sunlenca] [SBD] · 1.5 ML Sunlenca 309 MG/ML Injection [SY] · Sunlenca 463.5 MG per 1.5 ML Injection [SY]412These highlights do not include all the information needed to use SUNLENCA safely and effectively. See full prescribing information for SUNLENCA. SUNLENCA ® (lenacapavir) tablets, for oral use SUNLENCA ® (lenacapavir) injection, for subcutaneous use Initial U.S. Approval: 202220260312